An International Multicenter Study of Bevacizumab for Bleeding in Hereditary Hemorrhagic Telangiectasia (the InHIBIT-Bleed Study)

Hanny Al-Samkari, M.D., of Massachusetts General Hospital in Boston, MA, presented results on systemic bevacizumab for bleeding in hereditary hemorrhagic telangiectasia (HHT) from the InHIBIT-Bleed Study

Longitudinal Assessment of ADAMTS13 Activity Helps Predict Recurrence of Immune Thrombotic Thrombocytopenic Purpura: Results From the German TTP Registry

Charis von Auer-Wegener of the University Medical Center of the Johannes Gutenberg in Mainz, Germany, presented results from research investigating the role of ADAMTS13 activity in predicting recurrence of immune thrombotic thrombocytopenic purpura, or iTTP

Neutrophil Extracellular Traps and Inflammasomes Form an Inflammatory Circuit Promoting Venous Thrombosis

Joana Campos of the Institute of Cardiovascular Sciences, College of Medical and Dental Sciences at the University of Birmingham, United Kingdom, presented results from research that looked into the bidirectional interactions between inflammasomes and neutrophil extracellular traps (NETs) in the context of murine deep venous thrombosis (DVT)

Theme picker